Preprint · OA via OpenAlex

Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial

Mitzi M. Gonzales, Valentina R. Garbarino, Tiffany F. Kautz, Juan Pablo Palavicini, Marisa Lopez‐Cruzan, Shiva Kazempour Dehkordi, Julia Mathews, Habil Zare, Peng Xu, Bin Zhang, Crystal Franklin, Mohamad Habes, Suzanne Craft, Ronald C. Petersen, Tamar Tchkonia

Nature Medicine · 2023 · ▲ 242 citations

Cellular senescence Senolytics

＋ Sign in to save

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: OpenAlex
DOI: 10.1038/s41591-023-02543-w
Canonical: link ↗
Fetched: 2026-06-15 MST

Cite this

APA

Gonzales, M.M., Garbarino, V.R., Kautz, T.F., Palavicini, J.P., Lopez‐Cruzan, M., Dehkordi, S.K., Mathews, J., Zare, H., Xu, P., Zhang, B., Franklin, C., Habes, M., Craft, S., Petersen, R.C., Tchkonia, T., Kirkland, J.L., Salardini, A., Seshadri, S., Musi, N., & Orr, M.E. (2023). Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial. <em>Nature Medicine</em>. https://doi.org/10.1038/s41591-023-02543-w

Vancouver

Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez‐Cruzan M, Dehkordi SK, et al. Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial. Nature Medicine. 2023. doi:10.1038/s41591-023-02543-w.

BibTeX

@unpublished{mitzi2023Senoly, title = {Senolytic therapy in mild Alzheimer’s disease: a phase 1 feasibility trial}, author = {Mitzi M. Gonzales and Valentina R. Garbarino and Tiffany F. Kautz and Juan Pablo Palavicini and Marisa Lopez‐Cruzan and Shiva Kazempour Dehkordi and Julia Mathews and Habil Zare and Peng Xu and Bin Zhang and Crystal Franklin and Mohamad Habes and Suzanne Craft and Ronald C. Petersen and Tamar Tchkonia and James L. Kirkland and Arash Salardini and Sudha Seshadri and Nicolas Musi and Miranda E. Orr}, journal = {Nature Medicine}, year = {2023}, doi = {10.1038/s41591-023-02543-w}, }